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We recently showed that the L protein of Sendai virus is present as an oligomer in the active P–L polymerase complex [Smallwood et al.,
Virology 304 (2002) 235]. We now demonstrate using two different epitope tags that the L protein of a second respirovirus, human
parainfluenza type 3 virus (PIV3), also forms an L–L complex. L oligomerization requires the coexpression of the differentially epitope tagged
L proteins. By exploiting a series of C-terminal truncations the L–L binding site maps to the N-terminal half of L. There is some complex
formation between the heterologous PIV3 and Sendai L and P proteins; however, the heterologous L protein does not function in transcription
of either the PIV3 or Sendai template. The PIV3 C protein binds PIV3 L and inhibits RNA synthesis in vitro and in vivo. Significant homology
exists between the C proteins of PIV3 and Sendai and complex formation occurs between the PIV3 and Sendai heterologous C and L proteins.
In addition, the heterologous C proteins can inhibit transcription at f50% of the level of the homologous protein. These data suggest that
while the C proteins may be functionally somewhat interchangeable, the L and P proteins are specific for each virus.
D 2003 Elsevier Inc. All rights reserved.Introduction
The RNA-dependent RNA polymerase of paramyxovi-
ruses is a complex of the L and P proteins, where the L
protein is thought to contain all the catalytic activities
necessary for viral RNA synthesis (for a review, Lamb
and Kolakofsky, 2001). The P protein of many paramyx-
oviruses has been shown or predicted to be an oligomer
(Lamb and Kolakofsky, 2001) and the most detailed struc-
tural studies showed that Sendai P is a tetramer forming a
coiled coil in the functional polymerase (Tarbouriech et al.,
2000a,2000b). In Sendai, the L binding site mapped to the
C-terminal half on P at amino acids (aa) 412–479 (Curran et
al., 1994; Smallwood et al., 1994). The P subunit of the
polymerase functions in the stabilization and proper folding
of L, as coexpression of P and L is necessary for complex
formation, and L is unstable in the absence of P (Horikami
et al., 1992, 1997). The P genes of the respirovirus genus
within the paramyxovirus family encode multiple proteins
including the C and V proteins (Lamb and Kolakofsky,0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: smoyer@ufl.edu (S.A. Moyer).2001). In the case of Sendai, viral RNA synthesis is down-
regulated by the C proteins, by C binding to the L poly-
merase subunit (Cadd et al., 1996; Curran et al., 1992;
Grogan and Moyer, 2001; Horikami et al., 1997).
Sequence alignment of the L proteins of negative-strand-
ed RNA viruses revealed six distinct regions of conserva-
tion, designated as domains I–VI, which were proposed to
correspond to functional domains of the protein (Poch et al.,
1990; Sidhu et al., 1993). We have shown with a number of
site-directed Sendai L mutants that each conserved domain
contributes to multiple steps in viral RNA synthesis (Chan-
drika et al., 1995; Cortese et al., 2000; Feller et al., 2000a;
Horikami and Moyer, 1995; Smallwood et al., 1999,
2002a,2002b). While the functional role of each domain is
complex, the domains act in an independent fashion, be-
cause when pairs of inactive L mutants or a truncation of
wild-type (wt) L with a mutant L were coexpressed, viral
RNA synthesis is restored through intragenic complemen-
tation (Smallwood et al., 2002a,2002b). Consistent with
intragenic complementation the functional form of the L
protein was shown directly to be an oligomer by the
coimmunoprecipitation of L proteins carrying two different
epitope tags. Deletion analysis has shown that the L–L
interaction site maps within the N-terminal 200 aa of L
(Cevik et al., 2003). We identified amino acids in the N-
Fig. 1. Complex formation between PIV3 FL and truncated L proteins and heterologous L–L interactions. (A–C) A549 cells were infected with VVT7 and
then transfected with no plasmid (Mock) or PIV3 P and the indicated combinations of PIV3 full-length (FL) tagged L and truncated FLAG L plasmids. (D and
E) Infected cells were transfected with the indicated combinations of Sendai (SV) and PIV3 FL and truncated L plasmids in the absence of P plasmid. The cells
were incubated with Express-35S for 1 h and cytoplasmic extracts were prepared as described under Materials and methods. Samples of the extracts were either
analyzed directly by SDS-PAGE (Total) or immunoprecipitated with a-FLAG or a-HA antibodies as indicated. The positions of the proteins are indicated.
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essential for the binding of P, but are non-essential for L
binding (Cevik et al., 2003; Holmes and Moyer, 2002), so the
P and L binding sites on L are independent of one another. To
determine if the oligomerization of L protein might be a
general property of paramyxoviruses, we analyzed L of the
related respirovirus, human parainfluenza virus 3 (PIV3). We
show here that the L protein of PIV3 is also an oligomer
where the L–L interaction site resides in the N-terminal half
of L. Homologous and heterologous PIV3 and Sendai L, P
and C interactions were tested for their function in RNA
synthesis by both viruses.Results
PIV3 L protein forms an oligomer
To test if the L protein of another member of the
paramyxovirus family interacts with itself, PIV3 full-length
(FL) L protein was differentially epitope tagged. HA or
FLAG tags were cloned in frame at the 5V end of the L
coding sequence as described under Materials and methods.
Both tagged full-length (FL) L proteins were expressed at
wt L levels and were shown to be 90–100% as active as wt
L in viral RNA synthesis in a CAT reporter minigenome
assay (data not shown). A series of C-terminal truncations of
the FLAG FL L (2258 aa), designated FLAG Bam L, FLAG
Age L and FLAG Sph L with sizes of 1721, 1305 and 915
aa, respectively, were constructed by deletion of the FLAG
FL L plasmid as described under Materials and methods. To
test for L–L complex formation, the tagged proteins were
expressed in VVT7-infected cells by transfection of the P
plasmid and HA FL L and truncated FLAG L plasmids
separately or together and labeled with Express-35S. Anal-
ysis of total protein showed that all the proteins were
synthesized (Fig. 1A). Immunoprecipitation (IP) of the
extracts with a-FLAG (Fig. 1B, Lane 2) or a-HA (Fig.
1C, Lanes 3, 5, 7 and 9) antibodies showed only a trace
cross-reactivity for each antibody with the L protein with the
heterologous tag expressed alone. IP with a-FLAG for each
of the FLAG tagged truncations coimmunoprecipitated the
HA FL L (Fig. 1B, Lanes 6, 8 and 10). Similarly IP with a-
HA coprecipitated each of the FLAG truncations with the
HA FL L (Fig. 1C, Lanes 6, 8 and 10). The L–L complex
was also formed in a similar experiment in the absence of P
protein (Fig. 1D, Lane 5, bottom), so P is not required for
the interaction. The coimmunoprecipitation of a complex
with both antibodies suggests that the PIV3 L protein is anFig. 2. L oligomerization requires cotranslation of the proteins. VVT7-
infected cells were transfected with PIV3 P and the indicated HA FL L and/
or the FLAG Bam L plasmids. The cells were incubated with Express-35S
for 1 h, total cytoplasmic extracts were prepared and (A) samples separated
directly by SDS-PAGE. (B). Samples of Lanes 4 and 5 were mixed and all
the samples were immunoprecipitated with a-HA antibody and separated
by SDS-PAGE. The positions of the proteins are indicated.
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resides in the N-terminal 915 aa of the protein.
The N-terminal 876 aa of the L proteins of both PIV3 and
Sendai encompasses the conserved domains I–III. We tested
if heterologous L–L interactions could occur with the L
proteins of PIV3 and Sendai (SV) with the expectation that
with a positive result, the data might contribute to identify-
ing amino acids, perhaps in the conserved domains, required
for oligomerization. The HA-tagged FL L protein of each
virus was expressed with either a PIV3 or SV truncated
FLAG L in the absence of any P protein and analysis of the
total extract showed that all the proteins were expressed
(Figs. 1D and E, top). In the homologous interaction,
immunoprecipitation with a-FLAG antibody of PIV3Fig. 3. Binding of PIV3 gstP to FL and C-terminal truncations of PIV3 L and hete
and then transfected with no plasmid (Mock) or PIV3 gstP and the indicated
Express-35S for 1 h and cytoplasmic extracts were prepared as described under Ma
PAGE or (B) incubated with glutathione-Sepharose beads before analysis. (C) Infe
FL or truncated FLAG L plasmids and extracts immunoprecipitated with a-FLA
proteins were expressed with the homologous or heterologous untagged L protein
positions of the proteins are indicated.FLAG Bam L also brought down PIV3 HA FL L compared
with background binding with PIV3 HA FL L alone as
above (Fig. 1D, Lanes 3 and 5). In addition, a-FLAG
antibody coimmunoprecipitated SV FLAG Bak L and
PIV3 HA FL L (Lane 6, bottom). In the converse experi-
ment, immunoprecipitation with a-HA antibody of SV HA
FL L brought down the heterologous PIV3 FLAG Bam L as
well as the homologous SV FLAG Bak L (Fig. 1E, Lanes 5
and 6). When quantitated, these data show that heterologous
L–L complexes can occur between the L proteins of Sendai
and PIV3 at greater than 50% of the level of the homolo-
gous interactions.
To test the requirements for PIV3 L–L complex forma-
tion, we asked if the proteins must be coexpressed. Differ-rologous P–L interactions. (A and B) A549 cells were infected with VVT7
PIV3 FL or truncated FLAG L plasmids. The cells were incubated with
terials and methods. The extracts were either (A) analyzed directly by SDS-
cted cells were transfected with the PIV3 P plasmid and the indicated PIV3
G antibody. (D) To measure heterologous interactions, PIV3 or SV gstP
s as indicated, selected with glutathione beads and analyzed as above. The
Fig. 4. Effect of heterologous L proteins on in vitro mRNA synthesis from
PIV3 and Sendai templates. VVT7-infected cells were transfected with no
plasmids (Mock) or on the left with SV P and the indicated SV or PIV3
untagged, full-length L plasmids or on the right with PIV3 P and the
indicated PIV3 or SV L plasmids. Cytoplasmic extracts were prepared,
incubated with wt RNA-NP from SVor RNA-N from PIV3 as indicated and
[a-32P]CTP. The RNA transcripts were isolated and analyzed by agarose-
urea gel electrophoresis. The positions of the comigrating NP, P or N, P
transcripts are indicated.
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alone or together in the presence of P protein. Analysis of
the total sample showed that each of the proteins was
synthesized (Fig. 2A). Samples of HA FL L and FLAG
Bam L expressed alone (Lanes 4 and 5) were mixed and all
the samples were immunoprecipitated with a-HA antibody.
There was no cross-reactivity of the HA antibody with the
FLAG Bam L–P complex (Fig. 2B, Lane 3) and no L–L
complex formation was observed when HA FL L and FLAG
Bam L were synthesized separately and then mixed (Fig.
2B, Lane 4). However, FLAG Bam L was coimmunopreci-
pitated with HA FL L by a-HA when the two proteins were
translated together (Lane 5) as above. These data show that
PIV3 L–L complex formation requires the coexpression of
the L proteins.
Interaction of PIV3 and SV L with homologous and
heterologous P proteins
The P binding site on L for formation of the polymerase
complex has been studied for Sendai, SV5 and measles, but
not for any other paramyxovirus (Chandrika et al., 1995;
Holmes and Moyer, 2002; Horikami et al., 1994; Parks,
1994). The PIV3 C-terminal L truncations were therefore
tested for their ability to bind to PIV3 P utilizing a gluta-
thione-S-transferase (gst) P fusion protein and pull down
experiments with glutathione-Sepharose beads. PIV3 gstP
was shown to be as active as wt P in a PIV3 CAT reporter
minigenome replication assay (data not shown), and so was
a valid reagent for these experiments. VVT7-infected cells
were transfected with the gstP and full-length and C-
terminal deletion FLAG L plasmids and labeled with
Express-35S. Gel analysis of the total samples showed that
all the proteins were synthesized (Fig. 3A). As controls, gstP
alone bound to the beads, while the FL and truncated L
proteins alone did not (Fig. 3B, Lanes 2, 5, 7 and 9). When
coexpressed with gstP, FL L and both Bam L and Age L
bound with gstP to the beads (Fig. 3B, Lanes 4, 6 and 8),
showing complex formation. Sph L, however, was close to
the size of gstP so that complex formation could not be
assessed (Lane 10). As an alternative method, infected cells
were transfected with the FLAG FL and truncated L
plasmids and the P plasmid instead of gstP. IP with a-
FLAG showed a small amount of background with P alone,
but there was a significant increase of P coprecipitated with
FL L, Bam L and Age L, but not with Sph L (Fig. 3C).
While the longer truncated L proteins bound P, truncation at
aa 915 in Sph L abolished PIV3 P–L, but not L–L complex
formation. Thus, the P binding site resides in the N-terminal
1305 aa of L.
There is considerable homology in the N-terminal half of
the L proteins of PIV3 and Sendai (domains I–IV, Poch et
al., 1990; Sidhu et al., 1993). For the P proteins of the two
viruses, there is little homology in the N-terminal half
(23%), but 46% identity in the C-terminal 169 aa which
contains the L binding site (Matsuoka et al., 1991). Weasked if heterologous P–L interactions occurred since under
some conditions, PIV3, as well as PIV1, viruses, can
replicate a Sendai template (Curran and Kolakofsky, 1991;
Pelet et al., 1996). Infected cells were transfected with
combinations of homologous and heterologous untagged L
and gstP plasmids and complexes were selected with gluta-
thione-Sepharose beads. Neither SVor PIV3 L bound in the
absence of gstP, but as positive controls in the homologous
samples, SV L was cobound with SV gstP to beads and
PIV3 L and PIV3 gstP formed a complex (Fig. 3D, Lanes 2,
3, 6 and 7) as expected. When the heterologous interactions
were tested, SV L did form a complex with PIV3 gstP at
about 20% of the homologous interaction; however, in the
reverse, there was no interaction of PIV3 L with SV gstP
(Fig. 3D, Lanes 4 and 5), even in a longer exposure,
although all the L proteins were equally expressed (not
shown). The partial heterologous interaction in the one case
suggests that some amino acids in common between the P
proteins (and L proteins) of each virus are involved.
Heterologous L polymerase proteins do not function in RNA
synthesis
To test the functional consequences of the heterologous
L–L and P–L interactions that did occur (Figs. 1 and 3),
various combinations of P and L were tested for tran-
scription on homologous and heterologous templates (Fig.
4). Previous experiments had shown that the homologous
N protein is required for the Sendai and PIV3 poly-
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of one virus does not bind the heterologous nucleocapsid
(Pelet et al., 1996). However, it had not been tested if
heterologous L proteins could be utilized with the ho-
mologous P, which was addressed here. VVT7-infected
cells were transfected with no plasmids (Mock) or on the
left with SV P and the indicated untagged SV or PIV3 L
plasmids or on the right with PIV3 P and the indicated
untagged PIV3 or SV L plasmids. Cytoplasmic extracts
were prepared, incubated with polymerase-free wt RNA-
NP from SV on the left or RNA-N template from PIV3
on the right as indicated and assayed for transcription in
vitro under conditions optimal for each virus as described
under Materials and methods. The RNA transcripts wereFig. 5. Binding of PIV3 gstC to FL and C-terminal truncations PIV3 L and heterolo
then transfected with no plasmid (Mock) or PIV3 gstC and the indicated FL or trun
and cytoplasmic extracts were prepared. The extracts were either (A) analyzed dire
before analysis. (C). To measure heterologous interactions, the indicated PIV3 g
heterologous untagged, full-length L proteins, selected with glutathione beads anisolated and analyzed by agarose-urea gel electrophoresis.
In the Mock-transfected samples, there was no RNA
synthesis from either the PIV3 or SV template (Fig. 4,
Lanes 1 and 4) showing that no endogenous polymerase
remained with the templates. There was, however, good
transcription from each template with the homologous P
and L proteins, but no RNA synthesis from the homol-
ogous P with the heterologous L protein (Fig. 4, Lanes 2,
3, 5 and 6). Thus, even though the SV L protein could
form some complex with the PIV3 P protein, this
complex was not active in transcription of the PIV3
template. Virtually no complex occurred between PIV3
L and SV P consistent with the lack of activity on the SV
template.gous C–L interactions. (A and B) A549 cells were infected with VVT7 and
cated FLAG L plasmids. The cells were incubated with Express-35S for 1 h
ctly by SDS-PAGE or (B) were incubated with glutathione-Sepharose beads
stC or SV gstCVproteins were expressed with the indicated homologous or
d analyzed as above. The positions of the proteins are indicated.
/ Virology 318 (2004) 439–450 445Interaction of PIV3 L with homologous and heterologous C
proteins
In Sendai virus, the C protein binds the L polymerase
protein to inhibit viral RNA synthesis (Cadd et al., 1996;
Curran et al., 1992; Grogan and Moyer, 2001; Horikami et
al., 1997). To determine if these properties are the same for
PIV3, the PIV3 C-terminal L truncations were also tested
for their ability to bind to PIV3 gstC protein utilizing pull
down experiments as above. VVT7-infected cells were
transfected with the gstC and FL and C-terminal deletion
FLAG L plasmids alone or together and pulse labeled with
Express-35S. Gel analysis of the total samples showed that
all the proteins were synthesized (Fig. 5A). As controls for
C binding, gstC alone, but neither FL L nor the truncations
alone, bound to the beads (Fig. 5B, Lanes 2, 3, 5, 7 and 9).
The PIV3 gstC protein appears as two bands, so the protein
S. Smallwood, S.A. MoyerFig. 6. Effect of heterologous gstC proteins on RNA synthesis with PIV3 and SV t
minigenome CAT plasmid alone (mock) or with the P, L, N and minigenome CAT
gstC or SV gstCVplasmids. Extracts were assayed for CAT activity as described un
mock value (1000 cpm) compared to activity in the absence of gstC. (A, bottom)
antibody. (B) Infected cells were transfected with the PIV3 P and L plasmids with n
plasmids. Cytoplasmic extracts were prepared, incubated with PIV3 RNA-N templ
plasmids with no gstC or in the presence of the indicated amounts of PIV3 gstC or
RNA-NP template and [a-32P]CTP. In each case, the RNA transcripts were iso
products were quantitated and shown as the % Transcription (Transcrip.) relative to
less than 10% variation.seems to undergo either early termination or proteolysis in
cells, although not during in vitro transcription and transla-
tion in a rabbit reticulocyte lysate (data not shown). When
coexpressed with gstC, FL L and each L deletion cobound
to the beads (Lanes 4, 6, 8 and 10), showing that PIV3 C
does bind L and the C binding site resides in the N-terminal
half of the L protein. While the largest C-terminal deletion,
Sph L to 915 aa, inhibited L–P complex formation, the
overall structure of the protein was not disrupted, because
both C and L binding were retained with Sph L.
There is considerable homology throughout the C pro-
teins of PIV3 and SV with an overall identity of 41% and
58% in the C-terminal 94 aa of the protein (Luk et al.,
1986), so we asked if heterologous C–L interactions oc-
curred. Infected cells were transfected with homologous and
heterologous untagged FL L and gstC plasmids and com-
plexes selected with glutathione-Sepharose beads. Neitheremplates. (A, top) Infected cells were transfected in duplicate with the PIV3
plasmids in the absence or presence of the indicated amounts of the PIV3
der Materials and methods and the average is shown after subtraction of the
Immunoblot analysis of the gst fusion proteins in these extracts with a-gst
o gstC or in the presence of the indicated amounts of PIV3 gstC or SV gstCV
ate and [a-32P]CTP. (C) Infected cells were transfected with the SV P and L
SV gstCVplasmids. Cytoplasmic extracts were prepared, incubated with SV
lated and analyzed by agarose-urea gel electrophoresis. For B and C, the
the level of transcription without gstC as 100%. Duplicate experiments gave
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SV L was cobound with SV gstCV to beads and similarly
PIV3 L and PIV3 gstC formed a complex (Fig. 5C, Lanes 2,
3, 6 and 7). When the heterologous interactions were tested,
both SV L and PIV3 L did form a complex with the
heterologous gstC protein at about 30–50% of the homol-
ogous interaction (Fig. 5C, Lanes 4 and 5). Thus, amino
acids in common between the C proteins (and L proteins) of
the two viruses must be important for complex formation.
Heterologous C proteins inhibit viral RNA synthesis with
PIV3 and SV templates
To test the functional consequences of the observed
heterologous C–L interactions, the different C proteins were
tested for inhibition of overall RNA synthesis in a PIV3
reporter minigenome assay and for in vitro transcription on
homologous and heterologous templates (Fig. 6). In the CAT
reporter minigenome assay, T7 RNA polymerase transcribes
a minus sense CAT RNA containing the termini of PIV3
genomic RNA from a plasmid. Encapsidation by the N
protein creates a template that can be replicated and tran-
scribed by the viral P–L polymerase complex (Durbin et al.,
1997). VVT7-infected cells were transfected with plasmids
encoding the PIV3 P, N and L proteins, along with the pCAT
minigenome plasmid and increasing amounts of the PIV3
gstC or SV gstCVplasmids. CAT enzyme activity in extracts
of the cells was assayed as described under Materials and
methods as a measure of polymerase activity. The PIV3 L, P
and N proteins in the absence of gstC gave good levels of
minigenome transcription and replication (Fig. 6A, top). The
addition of increasing amounts of the homologous PIV3
gstC plasmid completely inhibited minigenome transcription
and replication. Gst itself gave no inhibition (data not
shown), showing that the inhibitory effect is due to the C
portion of the fusion protein. Similar amounts of the heter-
ologous SV gstCValso inhibited PIV3 RNA synthesis, but to
only 47% of the control. Immunoblot analysis of the samples
with a-gst antibody showed that SV gstCV was actually
expressed at higher levels than PIV3 gstC (Fig. 6A, bottom).
To measure just transcription from purified viral tem-
plates, VVT7-infected cells were transfected with no plas-
mids (Mock) or with PIV3 P and L and the indicated PIV3
gstC or SV gstCVplasmids (Fig. 6B) or with SV P and L and
the indicated SV or PIV3 gstC plasmids (Fig. 6C). Cyto-
plasmic extracts were prepared, incubated with polymerase-
free wt RNA-N template from PIV3 (B) or RNA-NP from
SV (C) and assayed for transcription in vitro. In the Mock-
transfected samples, there was no RNA synthesis from
either template; however, there was good transcription from
each template with the homologous P and L proteins (Fig.
6B and C, Lanes 1 and 2). Increasing amounts of PIV3 gstC
in the PIV3 reactions showed a dose dependent inhibition of
transcription, while SV gstCV gave 67% inhibition at the
highest concentration of protein (Fig. 6B). A similar result
was obtained in the converse heterologous experiment. Withthe SV template, homologous SV gstCV gave nearly com-
plete inhibition, but PIV3 gstC inhibited SV transcription by
only 50% (Fig. 6C). Thus, the interaction of PIV3 and SV C
proteins with the heterologous L proteins leads to signifi-
cant, but not complete inhibition of viral transcription,
suggesting contributions of virus-specific regions of C
protein to activity.Discussion
We recently demonstrated that the L protein of Sendai
virus is an oligomer within the P–L complex (Cevik et al.,
2003; Smallwood et al., 2002a,2002b) and wanted to test if
other members of the paramyxovirus family shared a similar
organization of the polymerase. We chose human parain-
fluenza virus 3 because it belongs to the same respirovirus
genus as Sendai virus, the P protein is an oligomer
(Choudhary et al., 2002; De et al., 2000) and has similar
mechanisms of transcription and replication, yet it is not as
closely related to Sendai virus as is human parainfluenza
virus 1. Coimmunoprecipitation of differentially epitope
tagged full-length and truncated PIV3 L proteins with anti-
bodies specific for the tag showed that an L–L complex
does form (Fig. 1), which does not depend on the P protein
within the P–L complex. Complex formation does require
the coexpression of the tagged L proteins (Fig. 2) consistent
with L oligomerization. The smallest C-terminal truncation
is 915 aa showing that the L-L binding site resides in the N-
terminal half of the protein. For Sendai virus in fact the
binding site resides within the N-terminal 200 aa (Cevik et
al., 2003). The exact nature of the L–L complex for Sendai
and PIV3 is not known and remains to be elucidated, but the
data show it is at the minimum a dimer. Similar experiments
in our laboratory have recently shown that the L protein of
measles virus, a member of the morbillivirus genus of
paramyxoviruses, also forms an L–L complex where the
binding site maps within the N-terminal 408 aa of L (B.
Cevik, S. Smallwood, E. Vrotsos and S.A. Moyer, unpub-
lished data), so we propose that oligomerization may be a
common feature of the L proteins of paramyxoviruses.
The availability of tagged C-terminal truncations of PIV3
L protein allowed the determination of the binding sites of
the viral P and C proteins which are expected to form
complexes with L protein. PIV3 P protein bound C-terminal
truncations of L to 1721 and 1305 aa but was abolished by
deletion to aa 915 (Fig. 3). Similar binding of the P proteins
of SV5 and Sendai requiring the N-terminal half of their
respective L proteins to form the polymerase complex was
previously reported (Chandrika et al., 1995; Parks, 1994),
but for measles virus, just the N-terminal 408 aa of L still
bound measles P (Horikami et al., 1994). Confirmation of
the importance of the very N terminus of L was shown by
site-directed mutants in both Sendai and PIV3 L which
abolished P binding (Holmes and Moyer, 2002; Malur et al.,
2002).
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directly, so we used the PIV3 L truncations to test C binding
to L and tested for its biological activity. The PIV3 C protein
bound to the full-length L and all the L truncations so a C–L
complex formed and the binding site mapped to the N-
terminal half of L, overlapping the L (Fig. 1) and P (Fig. 5)
binding sites. This is similar to the data for Sendai where the
C proteins bind to the N-terminal 895 aa of the Sendai L
polymerase subunit, overlapping but different than the P
binding site (Cevik et al., 2003; Holmes and Moyer, 2002;
Horikami et al., 1997). The C protein of rinderpest virus was
also shown to bind its L protein and infection with virus
lacking C in cell culture gave lower growth and was deficient
in mRNA synthesis (Baron and Barrett, 2000; Sweetman et
al., 2001). Like the inhibition of viral RNA synthesis by
Sendai C proteins (Cadd et al., 1996), analysis of PIV3 C
function by a minigenome reporter assay and in vitro
transcription showed that C inhibited PIV3 RNA synthesis
in each case (Fig. 6). Previous analysis of mutations in the C
protein of measles virus also showed that C inhibits measles
RNA synthesis (Reutter et al., 2001), presumably by also
binding L protein, so the inhibitory function of C proteins in
several different paramyxoviruses is similar.
To help in the identification of regions important for the
L–L, L–P and L–C interactions, we tested for protein–
protein interactions between heterologous PIV3 and Sendai
proteins and for biological function of these complexes in
the transcription and replication of both viruses. Positive
results would indicate that regions of like sequence between
heterologous proteins are responsible for the binding sites.
In fact the data showed that the L proteins of PIV3 and
Sendai did form complexes with each other and that PIV3
gstP did bind Sendai L, although unexpectedly, Sendai gstP
did not bind PIV3 L (Table 1). It was previously reported
that the PIV3 P–L complex did not function on the Sendai
template, nor did Sendai P–L transcribe the PIV3 template,
because the P protein of each polymerase was specific forTable 1
Homologous and heterologous interactions between Sendai (SV) and PIV 3
L, P and C proteins
Interactiona L–L L–P L–C
Binding
%b
Function
%c
Binding
%d
Function
%c
Binding
%e
Function
%f
PIV–PIV 100 100 100 100 100 100
PIV–SV >50 0 0 0 50 47–67
SV–PIV – – 20 0 30 50
SV–SV 100 100 100 100 100 100
a The virus derivation PIVor SV for each of the protein pairs at the top L–
L, L–P or L–C. The first component of each of the pairs (in bold)
represents the serotype of L (in bold) shown in the complexes (L–L, L–P
and L–C). The second component is the serotype of the interacting protein,
L, P or C.
b Data from Fig. 1.
c Data from Fig. 4.
d Data from Fig. 3.
e Data from Fig. 5.
f Data from Fig. 6.homologous assembled N protein in the nucleocapsid tem-
plate (Pelet et al., 1996). The function of just heterologous L
proteins in complex with the P protein specific for the
template was not tested. We show here that heterologous
P–L complexes are not active on either virus template (Fig.
4), and we found that increasing amounts of the heterolo-
gous L protein to active transcription reactions of each virus
did not act as dominant-negative proteins (S. Smallwood
and S.A. Moyer, unpublished data). Therefore, the heterol-
ogous Sendai and PIV3 P–L and L–L protein–protein
interactions that do occur must be somehow incomplete or
defective. Heterologous P and L interactions between Sen-
dai and another serotype of PIV, PIV1, have been tested by
Bousse et al. (2001). Coimmunoprecipitation experiments
showed complex formation between both SV P and PIV1 L
as well as PIV1 P and SV L, whereas we observed a
complex only with PIV3 P and SV L. Interestingly, the
PIV1 P-SV L enzyme was active on a Sendai template
(Bousse et al., 2001), although here PIV3 P-SV L was not
(Fig. 4), so sequence differences between the P proteins of
PIV3 and PIV1 must account for the loss of activity.
Analysis of heterologous C–L interactions showed that
the C proteins of both Sendai and PIV3 did bind to the
heterologous L proteins (Table 1). In other studies, site-
directed mutations in the C-terminal half of Sendai C gave
the loss of C binding to L and a loss of inhibitory activity
(Grogan and Moyer, 2001). Because these essential sites are
identical between the Sendai and PIV3 C proteins, we
predicted that the heterologous C protein would inhibit
RNA synthesis of each virus. In fact this was the case (Table
1), although inhibition was only to about 50% of the level of
the homologous C protein, suggesting that amino acids of C
specific for each virus, in addition to the identical sites in the
C proteins, are important for the function of the protein. It is
interesting that in a recent study, Kato et al. (2002) showed
that PIV3 infection of a cell line constitutively expressing the
smallest of the Sendai C proteins, Y2, had no effect on virus
yield, even though the data presented here showed that
Sendai C gave about a 50% inhibition of PIV3 RNA
synthesis in vitro. Apparently, the reduction in RNA synthe-
sis was not limiting in terms of virus production.Materials and Methods
Cells, viruses and antibodies
A549 human lung carcinoma cells were used for all
experiments. Sendai virus (Harris strain, SV) was propagated
in embryonated chicken eggs and polymerase-free nucleo-
capsid template (RNA-NP) was purified as described previ-
ously (Carlsen et al., 1985, Horikami et al., 1992). Wild-type
human PIV3 (JS) strain was grown in LLC-MK2 cells,
purified and polymerase-free nucleocapsid template purified
as described previously (Feller et al., 2000a,b). A vaccinia
virus recombinant which expresses the bacteriophage T7
S. Smallwood, S.A. Moyer / Virology 318 (2004) 439–450448RNA polymerase (VVT7) (Fuerst et al., 1986) was grown in
A549 cells. Antibodies included: rabbit anti-gst antibody
(Chandrika et al., 1995); anti-FLAG M-2 monoclonal anti-
body (a-FLAG, Sigma); and anti-HA probe F-7 monoclonal
antibody (a-HA, Santa Cruz Biotechnology, Inc.).
Plasmids
The pGem plasmids containing the Sendai virus L, NP
and Pstop (designated P, expressing only P due to a stop
codon in the C open reading frames) genes under the control
of the T7 promoter were described previously (Curran et al.,
1991). The Sendai pTM1gstP and pTM1gstCVplasmids were
described previously (Chandrika et al., 1995; Horikami et al.,
1997). The Sendai HA and FLAG tagged full-length and
truncated L plasmids were described in Smallwood et al.
(2002a,b). The pTMI plasmids for the PIV3 N, P (which
does not express C protein) and L genes and the minigenome
HPIV3-CAT +2 plasmid were described by Durbin et al.
(1997). The PIV3 pTM1-gstC plasmid was constructed by
PCR amplification of the C open reading frame from the
PIV3 P plasmid with primers containing BamHI and XhoI
restriction sites and cloned into pTM1-gst at those sites so
the gene was fused in frame at the C terminus of gst. The
correct gene was confirmed by sequencing. PIV3 pTM1-gstP
was constructed by subcloning P from pTM1-P into pTM1-
gst at the BamHI and SalI restriction sites so the gene was
fused in frame at the C terminus of gst.
To construct PIV3 L with HA or FLAG epitopes, the 5V
end of the L gene was first amplified by PCR with Vent
polymerase using an upstream primer with an AflII site
before the start of the L coding start site and a primer
downstream of the TthlllI site in L. The product was
digested with Tth111I and blunted with T4 DNA polymer-
ase, followed by digestion with AflII. This PIV3 L PCR
fragment was then cloned into the AflII and SmaI sites in
pTM1 vectors which contained either a FLAG or HA
epitope tag with an in frame AflII site at the 3V end (E.
Vrotsos and S. Moyer, unpublished data) to create interme-
diate vectors containing the 5Vend of PIV3 L fused to the 3V
terminus of each epitope tag. Transformants were screened
by PCR and positive clones confirmed by sequencing. To
construct HA and FLAG tagged full-length PIV3 L, PIV3
pTM1-L was digested with SalI and XcmI and cloned into
the epitope tagged intermediates at the SalI and XcmI sites.
The resulting clones were designated PIV3 FLAG L and
PIV3 HA L. To construct C-terminal truncations, PIV3 full-
length FLAG L was digested with BamHI and SalI, AgeI
and SalI, or SphI and SalI, blunted with T4 DNA polymer-
ase and ligated with T4 DNA ligase to yield: FLAG Bam L;
FLAG Age L; and FLAG Sph L, respectively.
Protein synthesis and analysis
A549 cells in 60-mm dishes were infected with VVT7 at
a multiplicity of infection (moi) of 2.5 pfu/cell for 1 h at37jC. In different experiments, the cells were then trans-
fected with the indicated combinations of plasmids PIV3
pTM1-P (0.6 Ag) or pTM1-gstP (0.6 Ag), the PIV3 tagged
full-length (0.9 Ag) or truncated pTM1-L (0.45 Ag), SV
pTM1-gstP (0.2 Ag), SV pGEM-L (5 Ag), truncated SV BaK
L (5 Ag) and PIV3 pTM1gstC (0.6 Ag) or SV pTM1-gstCV
(0.2 Ag) using lipofectin (Invitrogen Life Technologies)
according to the manufacturer’s protocol in Opti-MEM
(GIBCO). Eighteen hours posttransfection (p.t.), cells were
labeled with Express-35S (100 ACi/ml, Perkin-Elmer) for 1
h. Cytoplasmic extracts were prepared by scraping into 165
Al SV Salts (0.1 M HEPES [pH 8.5], 0.05 M NH4Cl, 7 mM
KCl, and 4.5 mM MgOAc, and 1 Ag/ml aprotinin) with
0.25% Nonidet P-40 (NP-40). The cell lysate was clarified
by pelleting for 30 min at 13,000 rpm and samples (70 Al)
used for immunoprecipitation (IP) or bead-binding. For IP,
the extracts were precleared with protein A beads (Sigma),
incubated with the relevant antibody (a-FLAG or a-HA, see
figure legends) according to the manufacturer’s protocol for
1 h at 4 jC and protein A beads were then added. The
immunocomplexes bound to the beads were pelleted,
washed, and separated by 7.5% SDS-PAGE on a 20-cm
gel. For gst bead-binding analysis, the samples were diluted
in SV Salts + 0.25% NP-40 to a total volume of 450 Al.
Blocked glutathione-Sepharose 4B beads (15 Al per sample,
Pharmacia Biotech) were incubated with extracts for 15 min
at 4 jC, pelleted and washed 3 in 800 Al SV Salts + 0.25%
NP-40. The proteins were separated by 7.5% SDS-PAGE on
a 20-cm gel and visualized by autoradiography. For immu-
noblot analysis, cell extracts used for the CAT analysis were
separated by 7.5% SDS-PAGE on a minigel and electro-
blotted onto nitrocellulose. The blot was probed with a-gst
antibody to detect the gstC fusion protein and developed
with conjugated goat anti-rabbit secondary antibody using
the Enhanced Chemiluminescence (ECL) Protein Identifi-
cation System (Amersham Life Science) according to the
manufacturer’s protocol.
PIV3 CAT minigenome assay and transcription in vitro
For the CAT assay, A549 cells (35-mm dishes) were
infected withVVT7 at a moi of 10 PFU/cell and transfected
with PIV3 pTM1-P (0.5 Ag), pTM1-N (0.5 Ag), pTM1-L
(0.15 Ag) and the CAT minigenome plasmid (0.5 Ag) in
lipofectin. The cells were incubated for 20 h, scraped and
pelleted, washed with 1 ml of 40 mM Tris, pH 7.5, 1 mM
EDTA, 150 mM NaCl and resuspended in 50 Al 0.25 M Tris,
pH 7.5. The lysate was prepared by three cycles of freeze–
thaw and clarified by centrifugation. For the CAT assay
(Sleigh, 1986), 40 Al of the supernatant was added to 60 Al of
reaction mix containing: 20 Al 8 mM chloramphenicol, 20
Al 14C-acetyl coenzyme A (5 ACi/ml) in 0.25 mM Tris–HCl,
pH 7.8 and 20 Al 0.25 M Tris–HCl, pH 7.8 and the samples
incubated at 37 jC for 2.5 h. The radiolabeled 14C-chlor-
amphenicol product was extracted with cold ethyl acetate
(100 Al) and quantitated in the scintillation counter.
S. Smallwood, S.A. Moyer / Virology 318 (2004) 439–450 449For mRNA synthesis, A549 cells in 60-mm dishes were
infected with VVT7 at an moi of 2.5 PFU/cell for 1 h at 37
jC and transfected with PIV3 pTM1-P (0.45 Ag) and pTM1-
L (0.15 Ag) in the absence or presence of the indicated
amounts of PIV3 pTM1-gstC or SV pTM1-gstCV in lip-
ofectin in Opti-MEM (Life Technologies) and incubated at
37 jC for 18 h p.t. Cytoplasmic extracts (100 Al) were
prepared using the lysolecithin procedure as described by
De et al. (1990) except NH4Cl was at 150 mM instead of 50
mM. The extracts were treated with micrococcal nuclease
(12 Ag/ml) in 1 mM CaCl2 for 30 min at 30 jC, EGTA (2.2
mM) added and then incubated with polymerase-free PIV3
RNA-N template (2 Ag) and [a32P]-CTP (40 ACi) for 2 h at
30 jC. The total labeled transcription products were purified
over RNeasy columns (Qiagen) and analyzed by electro-
phoresis on 1.5% agarose-acid-urea gels. The products were
visualized by autoradiography and quantitated using a
PhosphorImager (Molecular Dynamics).
Sendai virus transcription
A549 cells in 60-mm dishes were infected with VVT7 at
an moi of 2.5 PFU/cell for 1 h at 37 jC. The infected cells
were washed with Opti-MEM and transfected with SV L
(0.5 Ag) and SV P (1.5 Ag) plasmids in lipofectin in the
absence or presence of the indicated amounts of PIV3 gstC
or SV gstCV plasmids and incubated at 37 jC in Opti-MEM
(Life Technologies). At 18 h p.t., cytoplasmic extracts
(100 Al) were prepared using a modification of the lysolec-
ithin procedure (Horikami et al., 1992) where the cells are
scraped into incomplete reaction mix, micrococcal nuclease
digested and then supplemented with magnesium acetate,
RNasin, actinomycin D, creatine phosphate and creatine
phosphokinase (Chandrika et al., 1995). To assay for
mRNA synthesis, wt Sendai RNA-NP template (1 Ag) and
[a32P]-CTP (20 ACi) were added to each extract. After
incubation for 2 h at 30 jC, the total labeled products were
purified over RNeasy columns (Qiagen) and analyzed by
electrophoresis on 1.5% agarose-acid-urea gels. The prod-
ucts were visualized by autoradiography and quantitated
using a PhosphorImager.Acknowledgments
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